LENZ Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for LENZ Therapeutics, Inc. (LENZ) is 71.75M

According to LENZ Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.75M. This represents a change of -67.74% compared to the average of 222.42M of the last 4 quarters.

LENZ Therapeutics, Inc. (LENZ) Historical Enterprise Value (quarterly & annually)

How has LENZ Enterprise Value performed in the past?

The mean historical Enterprise Value of LENZ Therapeutics, Inc. over the last ten years is 440.28M. The current 71.75M Enterprise Value has changed -83.70% with respect to the historical average. Over the past ten years (40 quarters), LENZ's Enterprise Value was at its highest in in the September 2025 quarter at 1.30B. The Enterprise Value was at its lowest in in the March 2024 quarter at -100650950.87.

LENZ Therapeutics, Inc. (LENZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of LENZ Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LENZ Therapeutics, Inc. (LENZ) Average Enterprise Value

How has LENZ Enterprise Value performed in the past?

The current Enterprise Value of LENZ Therapeutics, Inc. (LENZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

LENZ Therapeutics, Inc. (LENZ) Enterprise Value vs. Peers

How is LENZ’s Enterprise Value compared to its peers?

LENZ Therapeutics, Inc.’s Enterprise Value is less than GH Research PLC (1.06B), less than ARS Pharmaceuticals, Inc. (466.75M), less than Nanobiotix S.A. (1.29B), less than Maravai LifeSciences Holdings, Inc. (3.99B), less than Rezolute, Inc. (365.60M), less than Geron Corporation (656.42M), less than Tyra Biosciences, Inc. (1.20B), less than Savara Inc. (960.13M), less than Prime Medicine, Inc. (870.34M), less than Arbutus Biopharma Corp (776.88M),

Build a custom stock screener for LENZ Therapeutics, Inc. (LENZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LENZ Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LENZ Therapeutics, Inc. (LENZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LENZ Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.